Parvizi, J. Et Al. 2023. Commentary on "Low Molecular Weight Heparin is Superior to Aspirin in the Prevention of Thromboembolic Disease, or is It? Response to an Editorial". JOURNAL OF ARTHROPLASTY , vol.38, no.4 .

Parvizi, J., DeMik, D. E., Hozack, W. J., Dunbar, M. J., Mont, M. A., & Lachiewicz, P. A., (2023). Commentary on "Low Molecular Weight Heparin is Superior to Aspirin in the Prevention of Thromboembolic Disease, or is It? Response to an Editorial". JOURNAL OF ARTHROPLASTY , vol.38, no.4.

Parvizi, JAVAD Et Al. "Commentary on "Low Molecular Weight Heparin is Superior to Aspirin in the Prevention of Thromboembolic Disease, or is It? Response to an Editorial"," JOURNAL OF ARTHROPLASTY , vol.38, no.4, 2023

Parvizi, JAVAD Et Al. "Commentary on "Low Molecular Weight Heparin is Superior to Aspirin in the Prevention of Thromboembolic Disease, or is It? Response to an Editorial"." JOURNAL OF ARTHROPLASTY , vol.38, no.4, 2023

Parvizi, J. Et Al. (2023) . "Commentary on "Low Molecular Weight Heparin is Superior to Aspirin in the Prevention of Thromboembolic Disease, or is It? Response to an Editorial"." JOURNAL OF ARTHROPLASTY , vol.38, no.4.

@article{article, author={JAVAD PARVİZİ Et Al. }, title={Commentary on "Low Molecular Weight Heparin is Superior to Aspirin in the Prevention of Thromboembolic Disease, or is It? Response to an Editorial"}, journal={JOURNAL OF ARTHROPLASTY}, year=2023}